JNJ
Johnson & Johnson · Healthcare · Drug Manufacturers - General
モメンタム指標（同類マネージャー）：
保有者の広がり -9.5% ·
株式フロー -2.2% ·
新規ネットポジション数 -10.5%
— 計算式
幅広い売り распределение — 株式数の減少と保有者数の縮小
すべての保有状況データ：追跡対象13Fマネージャーのみ、普通株ポジション、報告期間 Q3 2024
| 四半期 | 保有者 | Δ | 株数 | 報告済み評価額 | 新規 | 解消銘柄 |
|---|---|---|---|---|---|---|
| Q2 2026 | 183 | +1 | 1.45B | $367.13B | +5 | −3 |
| Q1 2026 | 184 | 0 | 1.43B | $348.29B | +4 | −5 |
| Q4 2025 | 183 | 0 | 1.52B | $314.40B | +2 | −1 |
| Q3 2025 | 28 | 0 | 887.20M | $164.46B | — | −1 |
| Q2 2025 | 26 | +1 | 740.96M | $113.15B | +1 | — |
| Q1 2025 | 22 | -1 | 281.15M | $46.60B | — | −1 |
| Q4 2024 | 23 | +3 | 290.64M | $42.01B | +3 | — |
| Q3 2024 | 19 | -2 | 157.55M | $25.50B | — | −2 |
| Q2 2024 | 21 | — | 161.11M | $23.53B | — | — |
| # | 運用会社 | 株数 | Δ株式数 | 時価 | そのウェイト | 保有中 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (パッシブ) | 56.11M | +1.8% | $9.06B | 0.7% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (パッシブ) | 56.11M | +1.8% | $9.06B | 0.7% | ▲ Add | 2 | SEC ↗ |
| 3 | Norges Bank ✦ (パッシブ) | 29.04M | -0.2% | $4.71B | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 25.16M | +1.0% | $4.08B | 0.5% | ▲ Add | 2 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 25.16M | +1.0% | $4.08B | 0.5% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 23.93M | -3.7% | $3.88B | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 23.93M | -3.7% | $3.88B | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 23.93M | -3.7% | $3.88B | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 23.93M | -3.7% | $3.88B | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 23.93M | -3.7% | $3.88B | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 23.93M | -3.7% | $3.88B | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 12 | Wellington Management ✦ | 23.93M | -3.7% | $3.88B | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 7.56M | +7.9% | $1.23B | 0.5% | ▲ Add | 2 | SEC ↗ |
| 14 | Marshall Wace ✦ | 5.27M | +35.7% | $854.30M | 1.1% | ▲ Add | 2 | SEC ↗ |
| 15 | Marshall Wace ✦ | 5.27M | +35.7% | $854.30M | 1.1% | ▲ Add | 2 | SEC ↗ |
| 16 | Marshall Wace ✦ | 5.27M | +35.7% | $854.30M | 1.1% | ▲ Add | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 3.16M | -5.7% | $509.92M | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 3.16M | -5.7% | $509.92M | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 3.16M | -5.7% | $509.92M | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 3.16M | -5.7% | $509.92M | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 3.16M | -5.7% | $509.92M | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 22 | Adage Capital Partners ✦ | 1.62M | +89.9% | $262.40M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 23 | Bridgewater Associates ✦ | 1.47M | -54.1% | $238.25M | 1.3% | ▼ Trim | 2 | SEC ↗ |
| 24 | Arrowstreet Capital ✦ | 1.15M | +39.2% | $186.83M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 25 | Tweedy, Browne ✦ | 1.13M | -0.4% | $182.51M | 8.7% | ▼ Trim | 2 | SEC ↗ |
| 26 | Citadel Advisors ✦ | 657.80K | -54.8% | $106.60M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 27 | Citadel Advisors ✦ | 657.80K | -54.8% | $106.60M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 28 | Markel Group ✦ | 610.80K | 0.0% | $98.99M | 0.9% | Held | 2 | SEC ↗ |
| 29 | Markel Group ✦ | 610.80K | 0.0% | $98.99M | 0.9% | Held | 2 | SEC ↗ |
| 30 | Gotham Asset Management ✦ | 217.64K | -0.2% | $35.27M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 31 | D. E. Shaw & Co. ✦ | 204.36K | -82.4% | $33.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 32 | D. E. Shaw & Co. ✦ | 204.36K | -82.4% | $33.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 33 | GAMCO Investors ✦ | 96.58K | -1.8% | $15.65M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 34 | Millennium Management ✦ | 81.37K | -92.4% | $13.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 35 | Fairfax Financial ✦ | 73.40K | 0.0% | $11.89M | 1.1% | Held | 2 | SEC ↗ |
| 36 | Dodge & Cox ✦ | 21.10K | 0.0% | $3.42M | 0.0% | Held | 2 | SEC ↗ |
「当該ウェイト」= そのマネージャーの報告済み13F株式評価額に占めるポジションの割合（確信度の指標）。✦ = キュレーション済みマネージャー。
新規買い手
| 今四半期は新規追跡買い手がいません。 |
ポジション解消済み
| Renaissance Technologies | $223.58M | だった 0.4% |
| Two Sigma Investments | $94.97M | だった 0.2% |
市場全体のコンテキスト: 全13Fファイラー対象（SEC構造化データ、 Q1 2026): 1 保有者, 136.10K 株式数, $33,268 報告済み. これは上記の追跡対象ユニバースの数値とは異なる、より古い期間のものであり、両者が混在することはありません。
この有価証券の追跡対象保有者が最も頻繁に保有する他の銘柄 — ファンダメンタルな関係ではなく、共同保有件数に基づきます。
市場内買い付け (P)
カバレッジ期間内にインサイダーによる市場内買い付けはありません。
市場内売却 (S)
Officer · 15.00K 株 · $3.95M
Officer, Director · 20.98K 株 · $5.50M
Officer, Director · 102.31K 株 · $26.70M
株式付与、権利行使および税務目的の株式差し引きは、買いや売りとして集計しません。 方法論
The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's drug to treat a…
Reuters